3Gustavo Saposnik,Femando Barinagarrementeria,Robert D. Brown,Cheryl D. Bushnell,Brett Cucchiara,Mary Cushman,Gabrielle deVeber,Jose M. Ferro,Fong Y. Tsai,张沈阳（译）,韩丽娟（译）,叶丹（译）,徐运（译）.脑静脉血栓形成的诊断和处理 美国心脏协会／美国卒中协会对医疗专业人员的声明[J].国际脑血管病杂志,2011,19(10):724-757. 被引量：210
2Eriksson UG. Bredberg U, Hoffmann KJ, et al. Absorption, distribution, metabolism,and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs,and humans [J]. Drug Metab Dispos ,2003,31 (3) : 294-305.
3Gustafsson D, Nystrom J, Carlsson S, et al. The direct thromhin inhibitor melagatran and its oral prodrug H376/95 : intestinal absorption properties, biochemical and pharmacodynamic effects [ J ].Thromb Res, 2001,101 ( 3 ) : 171 - 181.
4Deinum J,Gustavsson L, Gyzander E.et al. A thermodynamic characterization of the binding of thrombin inhibitors to human thrombin,combining biosensor technology,stopped-flow spectrophotometry, and microcalorimetr[ J ]. Anal Biochem ,2002,300(2) : 152-162.
5Johansson LC,Frison L, Logren U,et al. Influence of age on the pharmacokinel- ics and pharmaeodynamics of ximelagatran, an oral direct thrombin inhibitor [ J ]. Clin Pharmacokinet, 2003,42 ( 4 ) : 381-392.
6Wahlander K,Lapidus L,Olsson CG,et ah Pharmacokinelics,pharmacodynamics and clinical effects of the oral direel thrombin inhibitor ximelagatran in acule treatment of patients with pulmonary embolism and deep vein thrombosis [ J ]. Thromb Res,2002,107(3-4) : 93-99.
7Sarich TC, Wolzt M, Eriksson UG, et al. Effects of ximelagatran, an oral direct thrombin inhibitor,r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects [J].J Am Coll Cardiol,2003,41 (4) :557- 564.
8Gustafsson D, Antonsson T, Bylund R ,et ah Effects of melagatran,a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes [ J ]. Thromb Haemost,1998,79 ( 1 ) : 110-118.
9Sarich TC,Osende JI, Eriksson UG,et al. Acute antithrombotic effects of ximelagalran,an oral direct thrombin inhibitor,and r-hirudin in a human ex vivo model of arterial thrombosis [ J ]. J Thromb Haemost ,2003,1(5 ): 999-1004.
10Eriksson UG, Bredberg U, Gisle'n K.et al. Pharmacokinetics and pharmacodynamics of ximelagatran,a novel oral direct thrombin inhibitor, in young healthy male subjects [J]. Eur J Clin Pharmacol,2003,59 ( 1 ) : 35-43.
